Register
Community
Overview
Experts
Editors
Fellows
Code of conduct
Company
About Us
FAQs
Privacy Policy
Terms of Use
Careers
Programs
News
News Releases
Press Coverage
Publications
Blog
Contact Us
Sign in
Please select the option that best describes you:
Topics:
Epilepsy
•
Internal Medicine
•
Neurology
How do you approach use of newer anti-seizure medications for epilepsy patients on DOACs?
Related Questions
When do you consider ketamine to treat nonconvulsive status epilepticus?
How do you adjust the loading and maintenance doses for Keppra when treating status epilepticus in patients with ESRD, patients on HD, or patients on CVVH?
How do you approach anti-seizure medication management when it was started by another team for a seizure-naive patient before/after craniotomy for a tumor?
How do you decide the length of a routine EEG?
In well-controlled epilepsy patients who suffer an unprovoked seizure with medication compliance, what would prompt you to increase their anti-seizure medication?
What prompts you to consider prescribing different formulations of benzodiazepines for a seizure rescue medication?
What prompts you to procure EEG and/or imaging in patients presenting with multiple simple febrile seizures?
What recommendations would you make for a patient on long-term phenytoin due to epilepsy with a newly diagnosed breast cancer requiring doxorubicin as part of her chemotherapy?
When do you consider stenting in patients with recurrent stroke with ICAD?
How do you approach use of DMARDs and/or biologics for inflammatory arthritis in patients with a history of seizure disorder on anti-epileptic medications?
